Tempus AI (TEM) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Tempus AI (TEM) do?
Tempus AI Inc (TEM) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells diagnostic genomic testing kits and sequencing services directly to oncology clinics and hospitals. Combines laboratory genetic sequencing with clinical medical records to help physicians select personalized cancer. It is worth $10.87B on the market and sold $1.51B over the last year.
- Market cap
- $10.87B
- P/E ratio
- None (reported a loss)
- Annual sales
- $1.51B
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 18, 2026
Brands and businesses behind TEM
- Highline Sciences: Manages oncology clinical trials for biotechnology sponsors to generate fee-for-service research revenue.
TEM’s flags, in plain English
Each flag is a number from Tempus AI’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 18, 2026.
Still Climbing
Sales up 46.6% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Insiders Hold
Insiders own 40% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Stupid Cash
Can pay this year's bills 2.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Debt Is Driving
Heavy debt, 286% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about TEM
How big is Tempus AI?
Tempus AI’s market cap is $10.87B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.51B: what customers paid the company over the last year, before any costs.
What is TEM’s P/E ratio?
TEM has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with TEM?
The business generates substantial ongoing operating losses, with net losses exceeding two hundred million dollars annually. That is one risk on Tempus AI’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Tempus AI’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TEM’s filings on SEC.gov. The Margin Monkey is research, not advice.
